Intervention Review

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

  1. Eliza Prefontaine2,
  2. Lloyd R Sutherland1,*,
  3. John K MacDonald3,
  4. Monica Cepoiu2

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 25 AUG 2008

DOI: 10.1002/14651858.CD000067.pub2

How to Cite

Prefontaine E, Sutherland LR, MacDonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD000067. DOI: 10.1002/14651858.CD000067.pub2.

Author Information

  1. 1

    University of Calgary, Calgary, Alberta, Canada

  2. 2

    University of Calgary, Department of Community Health Sciences, Calgary, Alberta, Canada

  3. 3

    Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

*Lloyd R Sutherland, University of Calgary, Treatment Research Wellness Building, Room 3D08, Calgary, Alberta, T2N 4Z6, Canada.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009


Cited in:


This article has been cited by:

  1. 1
    Heimo H. Wenzl, Christian Primas, Gottfried Novacek, Alexander Teml, Anna Öfferlbauer-Ernst, Christoph Högenauer, Harald Vogelsang, Wolfgang Petritsch, Walter Reinisch, Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease, Digestive Diseases and Sciences, 2015, 60, 5, 1414